Actinomycosis: Difference between revisions
No edit summary |
|||
| Line 39: | Line 39: | ||
==Treatment== | ==Treatment== | ||
[[Actinomycosis medical therapy|Medical therapy]] | [[Actinomycosis surgery|Surgery]] | [[Actinomycosis primary prevention|Primary Prevention]] | [[Actinomycosis secondary prevention|Secondary Prevention]] | [[Actinomycosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Actinomycosis future or investigational therapies|Future or Investigational Therapies]] | [[Actinomycosis medical therapy|Medical therapy]] | [[Actinomycosis surgery|Surgery]] | [[Actinomycosis primary prevention|Primary Prevention]] | [[Actinomycosis secondary prevention|Secondary Prevention]] | [[Actinomycosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Actinomycosis future or investigational therapies|Future or Investigational Therapies]] | ||
*'''Actinomyces species including A. israeli'''<ref>{{cite book | last = Bennett | first = John | title = Mandell, Douglas, and Bennett's principles and practice of infectious diseases | publisher = Elsevier/Saunders | location = Philadelphia, PA | year = 2015 | isbn = 978-1455748013 }}</ref> | |||
:*Preferred regimen: [[Penicillin]] 3-4 million units IV q4h for 2-6 weeks {{then}} [[Penicillin V]] 2-4 g/day PO qid for 6-12 months | |||
:*Alternative regimen (1): [[Erythromycin]] 500-1000 mg IV q6h {{or}} 500 mg PO qid | |||
:*Alternative regimen (2): [[Tetracyclin]] 500 mg PO qid | |||
:*Alternative regimen (3): [[Doxycycline]] 100 mg IV q12h {{or}} 100 mg PO bid | |||
:*Alternative regimen (4): [[Clindamycin]] 900 mg IV q8h {{or}} 300-450 mg PO qd | |||
:*Alternative regimen (5): [[Minocycline]] 100 mg IV q12h {{or}} 100 mg PO bid | |||
== Acknowledgements == | == Acknowledgements == | ||
Revision as of 20:22, 28 July 2015
For patient information click here
| Actinomycosis | |
 | |
|---|---|
| A patient with Actinomycosis on the right side of the face. | |
| ICD-10 | A42 |
| ICD-9 | 039 |
| DiseasesDB | 145 |
| MeSH | D000196 |
|
Actinomycosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Actinomycosis On the Web |
|
American Roentgen Ray Society Images of Actinomycosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Actinomyces; actinomyces israeli;
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Actinomycosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
- Actinomyces species including A. israeli[1]
- Preferred regimen: Penicillin 3-4 million units IV q4h for 2-6 weeks THEN Penicillin V 2-4 g/day PO qid for 6-12 months
- Alternative regimen (1): Erythromycin 500-1000 mg IV q6h OR 500 mg PO qid
- Alternative regimen (2): Tetracyclin 500 mg PO qid
- Alternative regimen (3): Doxycycline 100 mg IV q12h OR 100 mg PO bid
- Alternative regimen (4): Clindamycin 900 mg IV q8h OR 300-450 mg PO qd
- Alternative regimen (5): Minocycline 100 mg IV q12h OR 100 mg PO bid
Acknowledgements
The content on this page was first contributed by: Dr. Steve Wiviott
de:Aktinomykose gl:Actinomicose hr:Aktinomikoza nl:Actinomycose sr:Актиномикоза fi:Aktinomykoosi uk:Актиномікоз
- ↑ Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1455748013.